Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2491 to 2505 of 8314 results

  1. Intralesional cryotherapy for keloid scars

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Chemical Component Separation

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. Extracorporeal bioartificial liver assist therapy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Inserting a bupivicaine-collagen implant into a surgical wound for postoperative analgesia

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Noninvasive Vagus Nerve Stimulation For reactive airway disease

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. Transbronchial lung cryobiopsy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  7. Vaginal microbiota seeding for neonates

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  8. Mechanical Thrombectomy for PE

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  9. Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after first-line systemic treatment [ID6463]

    In development Reference number: GID-TA11590 Expected publication date: TBC

    Technology appraisal guidance
    In development

  10. Inavolisib with fulvestrant for treating recurrent hormone receptor-positive HER2-negative PIK3CA-mutated locally advanced or metastatic breast cancer after a CDK 4-6 inhibitor [ID6650]

    In development Reference number: GID-TA11862 Expected publication date: TBC

    Technology appraisal guidance
    In development

  11. Belzutifan with pembrolizumab for adjuvant treatment of clear cell renal cell carcinoma after nephrectomy [ID6645]

    In development Reference number: GID-TA11813 Expected publication date: TBC

    Technology appraisal guidance
    In development

  12. Domvanalimab with zimberelimab for untreated unresectable advanced gastric, gastro-oesophageal junction or oesophageal cancer [ID6606]

    In development Reference number: GID-TA11801 Expected publication date: TBC

    Technology appraisal guidance
    In development

  13. Gemcitabine intravesical delivery system for treating high-risk non-muscle-invasive bladder cancer untreated with BCG [ID6658]

    Awaiting development Reference number: GID-TA11868 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Nusinersen and risdiplam for treating spinal muscular atrophy (review of TA588 and TA755) [ID6195]

    In development Reference number: GID-TA11386 Expected publication date: TBC

    Technology appraisal guidance
    In development

  15. CaRi-Heart for predicting cardiac risk in adults with suspected coronary artery disease (CAD)

    In development Reference number: GID-HTE10085 Expected publication date: TBC

    Health technology evaluations
    In development